We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bioequivalence Study by FDA May Begin This Year
Bioequivalence Study by FDA May Begin This Year
February 2, 2010
An NIH-FDA study of bioequivalence for generic and brand epilepsy drugs, expected to begin by next year, may change the way the FDA and healthcare providers look at bioequivalence, experts say.